Healthcare Week in Review April 8, 2017

Alston & Bird Healthcare Week in Review, April 8, 2017

I. Regulations, Notices, & Guidance

Event Notices

  • April 12, 2017: the Food and Drug Administration (FDA) announced a public workshop regarding new developments and scientific issues related to antibody mediated rejection (AMR) in kidney transplantation. The public workshop is intended to provide information for and gain perspective from individuals, industry, health care professionals, researchers, public health organizations, patients, patient care providers, and other interested persons on various aspects of clinical development of medical products for prophylaxis and/or treatment of AMR in kidney transplant recipients, including clinical trial design and endpoints.
  • April 13, 2017: The FDA announced a public advisory committee meeting of the Antimicrobial Drugs Advisory Committee. The committee will discuss the development of antibacterial drugs that treat a single species of bacteria when the target species infrequently causes infections; examples of such drugs include those that are only active against Pseudomonas aeruginosa or Acinetobacter baumannii.
  • May 3 – 5, 2017: The FDA Cincinnati District, in co-sponsorship with Xavier University, announced a public conference entitled, FDA/Xavier University Medical Device Conference (MedCon). The 3-day public conference includes presentations from key FDA officials and industry experts with small group break-out sessions. The conference is intended for companies of all sizes and employees at all levels.

II. Congressional Legislation & Committee Action

U.S. Senate
  • On April 4, 2017, the Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing entitled, FDA User Fee Agreements: Improving Medical Product Regulation and Innovation for Patients Part II. The witnesses included Kay Holcombe, Senior Vice President for Science Policy at the Biotechnology Innovation Organization; David Gaugh, Senior Vice President of Sciences and Regulatory Affairs at the Association for Accessible Medicines; Scott Whitaker, President and CEO of the Advanced Medical Technology Association; and Cynthia Bens, Vice President of Public Policy at the Alliance for Aging Research.
  • On April 5, 2017, the Senate HELP Committee held a hearing on the nomination of Scott Gottlieb to be Commissioner of the FDA.
House of Representatives
  • On April 5, 2017, the House Appropriations Labor, Health and Human Services, Education, and Related Agencies Subcommittee held a hearing entitled, Opioid Abuse Crisis Response. The witnesses included Barbra Cimaglio, Deputy Commissioner, Vermont Department of Health; Bill Guy Advocate, Parents Helping Parents; Nancy Hale, President and CEO, Operation UNITE; and Rosalie Liccardo Pacula ,Senior Economist and Co-Director, Drug Policy Research Center, RAND Corporation.

Upcoming Congressional Floor and Committee Action

U.S. Senate

  • The Senate has adjourned and will reconvene on Monday, April 24, 2017.
House of Representatives
  • The House has adjourned and will reconvene on Tuesday, April 25, 2017.
III. Reports, Studies, & Analyses  
  • On April 4, 2017, the Congressional Budget Office (CBO) released a working paper entitled, An Analysis of Private-Sector Prices for Hospital Admissions. The paper compares the hospital payment rates of three larger insurers’ commercial plans and Medicare Advantage plans with Medicare’s fee-for-service rates. It also examines the variation of those rates across and within markets.

IV. Other Health Policy News

  • On April 3, 2017, CMS released a fact sheet entitled, 2018 Medicare Advantage and Part D Rate Announcement and Call Letter, and Request for Information. The fact sheet outlines the finalized updates to the methodologies used to pay MA plans and Part D sponsors.
  • On April 4, 2017, CMS released a question and answer document entitled, Home Health Pre-Claim Review (PCR) Demonstration Pause Questions and Answers. The document answers questions related to the pausing of the Pre-Claim Review Demonstration.
  • On April 6, 2017, CBO released Answers to Questions for the Record Following a Hearing on the Budget and Economic Outlook for 2017 to 2027 Conducted by the Senate Committee on the Budget. The Senate Budget Committee convened a hearing at which Director Keith Hall testified about CBO’s report The Budget and Economic Outlook: 2017 to 2027. This document provides CBO’s answers to questions submitted for the record.
  • On April 6, 2017, CMS announced the participants for two of the tracks, the Assistance and Alignment Tracks, of the Accountable Health CommunitiesA list of the Assistance and Alignment Tracks bridge organizations in the Accountable Health Communities Model can be found here.

V. ACA Repeal News

  • On April 6, 2017, the House Rules Committee reconvened a meeting regarding legislation to repeal and replace the Affordable Care Act (ACA), entitled H.R. 1628, the “American Health Care Act” (AHCA). The Rules Committee adopted a Rule (by a vote of 9-2) that provides for further consideration of the AHCA with an amendment from Representatives Gary Palmer (R-AL) and David Schweikert (R-AZ)being self-executed into the legislation. The amendment would allocate $15 billion from the Patient and State Stability Fund from 2018 to 2026 to create a federal “invisible risk sharing program.” The amendment can be found here.
  • House Rules Committee Chairman Pete Sessions (R-TX) suggested that the House intends to vote on the AHCA legislation upon its return from Easter Recess.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222
This website uses cookies to improve functionality and performance. By continuing to browse this site, you are consenting to the use of cookies on this website. For details, see our Privacy Statement